Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.94 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Share-based Compensation (IS) (2025)

Updated

Polaryx Therapeutics' Share-based Compensation (IS) was $108,000 in Q2 2025.

Analysis

Polaryx Therapeutics (PLYX) Share-based Compensation (IS) (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,149.24 Bn 1,117.83 Bn 19.71 Bn -
2 Johnson & Johnson 636.01 Bn 555.87 Bn 17.30 Bn -
3 AbbVie 500.63 Bn 473.74 Bn 12.70 Bn -
4 Merck 357.88 Bn 312.26 Bn 12.21 Bn -
5 Novartis Ag 301.63 Bn 265.62 Bn 11.24 Bn -
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn -
7 Amgen 238.20 Bn 193.60 Bn 7.24 Bn -
8 Gilead Sciences 194.85 Bn 169.05 Bn 6.22 Bn -
9 Pfizer 171.94 Bn 118.58 Bn 10.94 Bn -
10 Polaryx Therapeutics 96.70 Mn 72.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 108,000.00
API Access

Polaryx Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=PLYX&period=max&api_key=YOUR_API_KEY